2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Leukemia
26
Lymphoma, Non-Hodgkin
18
Sarcoma
17
Leukemia, Myeloid, Acute
16
Hematologic Neoplasms
12
Neuroblastoma
11
Neoplasms
11
Myelodysplastic Syndromes
11
Hodgkin Disease
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Breast Neoplasms
9
Burkitt Lymphoma
8
Osteosarcoma
6
Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Melanoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Rhabdoid Tumor
4
Retinoblastoma
4
Recurrence
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Myeloproliferative Disorders
4
Medulloblastoma
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Hematologic Diseases
4
Interventions
fludarabine
4
fludarabine phosphate
3
Cyclophosphamide
3
AP 1903 reagent
2
thymoglobulin
1
ruxolitinib
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Erythrocyte Count
1
Dexamethasone
1
Clofarabine
1
Busulfan
1
Bortezomib
1
Blood Transfusion
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thalassemia
×
Mesna
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts